SCHEMBL24180245

SCHEMBL24180245

COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4C2C2ON=C(SC)C2[C@H]3c2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ EIF4A1 P60842 15/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ ABHD10 Q9NUJ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17396544 0.78 CYP3A4 (0.47) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006140 0.75 CYP3A4 (0.49) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006501 0.73 CYP3A4 (0.47) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006458 0.73 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006092 0.73 EIF4A1 (0.51) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006160 0.70 MEN1 (0.42) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006485 0.68 MEN1 (0.43) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006149 0.67 CYP3A4 (0.42) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006161 0.67 CYP3A4 (0.43) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1
SCHEMBL20006331 0.67 CYP3A4 (0.41) CYP3A4ALDH1A1TSHRCYP2C19EIF4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998257-A1 FLAVAGLINE DERIVATIVES PIERRE FABRE MEDICAMENT (FR) 2022-05-18 — — EP disclosed
EP-3418273-B1 FLAVAGLINE DERIVATIVES PF MEDICAMENT (FR) 2022-01-12 — — EP disclosed
Send feedback